127 related articles for article (PubMed ID: 26239118)
21. Altered Expression of Three EGFR Posttranslational Regulators MDGI, MIG6, and EIG121 in Invasive Breast Carcinomas.
Meseure D; Drak Alsibai K; Vacher S; Hatem R; Nicolas A; Callens C; Lerebours F; Bieche I
Anal Cell Pathol (Amst); 2020; 2020():9268236. PubMed ID: 32377505
[TBL] [Abstract][Full Text] [Related]
22. MIG6 Is MEK Regulated and Affects EGF-Induced Migration in Mutant NRAS Melanoma.
Vu HL; Rosenbaum S; Capparelli C; Purwin TJ; Davies MA; Berger AC; Aplin AE
J Invest Dermatol; 2016 Feb; 136(2):453-463. PubMed ID: 26967478
[TBL] [Abstract][Full Text] [Related]
23. Regulation of the ErbB network by the MIG6 feedback loop in physiology, tumor suppression and responses to oncogene-targeted therapeutics.
Anastasi S; Lamberti D; Alemà S; Segatto O
Semin Cell Dev Biol; 2016 Feb; 50():115-24. PubMed ID: 26456277
[TBL] [Abstract][Full Text] [Related]
24. Inhibition of the EGF receptor by binding of MIG6 to an activating kinase domain interface.
Zhang X; Pickin KA; Bose R; Jura N; Cole PA; Kuriyan J
Nature; 2007 Nov; 450(7170):741-4. PubMed ID: 18046415
[TBL] [Abstract][Full Text] [Related]
25. The antitumorigenic function of EGFR in metastatic breast cancer is regulated by expression of Mig6.
Wendt MK; Williams WK; Pascuzzi PE; Balanis NG; Schiemann BJ; Carlin CR; Schiemann WP
Neoplasia; 2015 Jan; 17(1):124-33. PubMed ID: 25622905
[TBL] [Abstract][Full Text] [Related]
26. DNAJB1 stabilizes MDM2 and contributes to cancer cell proliferation in a p53-dependent manner.
Qi M; Zhang J; Zeng W; Chen X
Biochim Biophys Acta; 2014 Jan; 1839(1):62-9. PubMed ID: 24361594
[TBL] [Abstract][Full Text] [Related]
27. Tyrosine phosphorylation of mig6 reduces its inhibition of the epidermal growth factor receptor.
Wang Z; Raines LL; Hooy RM; Roberson H; Leahy DJ; Cole PA
ACS Chem Biol; 2013 Nov; 8(11):2372-6. PubMed ID: 24004111
[TBL] [Abstract][Full Text] [Related]
28. Mig6 not only inhibits EGFR and HER2 but also targets HER3 and HER4 in a differential specificity: Implications for targeted esophageal cancer therapy.
Zhong H; He J; Yu J; Li X; Mei Y; Hao L; Wu X
Biochimie; 2021 Nov; 190():132-142. PubMed ID: 34293452
[TBL] [Abstract][Full Text] [Related]
29. Truncation, modification, and optimization of MIG6(segment 2) peptide to target lung cancer-related EGFR.
Yu XD; Yang R; Leng CJ
Comput Biol Chem; 2016 Apr; 61():251-7. PubMed ID: 26967626
[TBL] [Abstract][Full Text] [Related]
30. Mitogen-inducible gene 6 is an endogenous inhibitor of HGF/Met-induced cell migration and neurite growth.
Pante G; Thompson J; Lamballe F; Iwata T; Ferby I; Barr FA; Davies AM; Maina F; Klein R
J Cell Biol; 2005 Oct; 171(2):337-48. PubMed ID: 16247031
[TBL] [Abstract][Full Text] [Related]
31. Negative regulation of the EGFR-MAPK cascade by actin-MAL-mediated Mig6/Errfi-1 induction.
Descot A; Hoffmann R; Shaposhnikov D; Reschke M; Ullrich A; Posern G
Mol Cell; 2009 Aug; 35(3):291-304. PubMed ID: 19683494
[TBL] [Abstract][Full Text] [Related]
32. Suppression of Mig-6 overcomes the acquired EGFR-TKI resistance of lung adenocarcinoma.
Kang DH; Jung SS; Yeo MK; Lee DH; Yoo G; Cho SY; Oh IJ; Kim JO; Park HS; Chung C; Lee JE
BMC Cancer; 2020 Jun; 20(1):571. PubMed ID: 32552717
[TBL] [Abstract][Full Text] [Related]
33. Understanding the MIG6-EGFR Signaling Axis in Lung Tumorigenesis.
Izumchenko E; Sidransky D
Cancer Discov; 2015 May; 5(5):472-4. PubMed ID: 25941338
[TBL] [Abstract][Full Text] [Related]
34. Mig6 reduces inflammatory mediators production by regulating the activation of EGFR in LPS-induced endotoxemia.
Chen W; Zhong H; Wang X; Pang Q; Zhuang J; Hu J; Chen Y; Hu J; Liu J; Tang J
J Cell Physiol; 2018 Sep; 233(9):6975-6983. PubMed ID: 29336487
[TBL] [Abstract][Full Text] [Related]
35. Mitogen-inducible gene 6 triggers apoptosis and exacerbates ER stress-induced β-cell death.
Chen YC; Colvin ES; Maier BF; Mirmira RG; Fueger PT
Mol Endocrinol; 2013 Jan; 27(1):162-71. PubMed ID: 23204325
[TBL] [Abstract][Full Text] [Related]
36. Mig-6 overcomes gefitinib resistance by inhibiting EGFR/ERK pathway in non-small cell lung cancer cell lines.
Li ZX; Qu LY; Wen H; Zhong HS; Xu K; Qiu XS; Wang EH
Int J Clin Exp Pathol; 2014; 7(10):7304-11. PubMed ID: 25400829
[TBL] [Abstract][Full Text] [Related]
37. CGRRF1, a growth suppressor, regulates EGFR ubiquitination in breast cancer.
Lee YJ; Ho SR; Graves JD; Xiao Y; Huang S; Lin WC
Breast Cancer Res; 2019 Dec; 21(1):134. PubMed ID: 31801577
[TBL] [Abstract][Full Text] [Related]
38. The non-receptor tyrosine kinase Ack1 regulates the fate of activated EGFR by inducing trafficking to the p62/NBR1 pre-autophagosome.
Jones S; Cunningham DL; Rappoport JZ; Heath JK
J Cell Sci; 2014 Mar; 127(Pt 5):994-1006. PubMed ID: 24413169
[TBL] [Abstract][Full Text] [Related]
39. Glucocorticoid-induced suppression of β-cell proliferation is mediated by Mig6.
Colvin ES; Ma HY; Chen YC; Hernandez AM; Fueger PT
Endocrinology; 2013 Mar; 154(3):1039-46. PubMed ID: 23384834
[TBL] [Abstract][Full Text] [Related]
40. Coupled folding-upon-binding of human tumor suppressor MIG6 to lung cancer EGFR kinase domain and molecular trimming/stapling of MIG6-derived β-hairpins to target the coupling event.
He Q; Xu S; Ma X; Ling T; Feng W; Lu X; Liu W; Chen Z
Eur Biophys J; 2023 Feb; 52(1-2):17-25. PubMed ID: 36547692
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
